Catalyst Biosciences Inc. (CBIO)
Gyre Therapeutics Announces First Dosing in Phase 1 Trial of F230 for Pulmonary Arterial Hypertension in China
Gyre Therapeutics Announces First Dosing in Phase 1 Trial of F230 for Pulmonary Arterial Hypertension in China
MustGrow and Phospholutions Sign Canadian Distribution Agreement for Phosphorous Efficiency Product – RhizoSorb®
AirSculpt Announces Pricing of Offering of Common Stock
Pharvaris Announces Annual Meeting of Shareholders
Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs
Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site
Innoviva Specialty Therapeutics Receives FDA New Drug Application Acceptance for Zoliflodacin, a First-in-Class Oral Antibiotic for Uncomplicated Gonorrhea in Adults
Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
Molecular Partners Announces Planned Operational Efficiencies and Extension of Cash Runway
Q & M Dental Group (Singapore) Limited - Announcement